Recent advancements in cancer immunotherapy have highlighted glypican-3 (GPC3) as a prominent target for treating hepatocellular carcinoma (HCC). However, approximately 10% to 30% of HCC patients ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

GLI’s #OctoberIs4Livers Campaign Calls for Collective Action on Early Detection and ScreeningWashington, D.C., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Today is the start of Global Liver Institute’s annual ...

A Memphis teen who has already endured unimaginable health challenges got to celebrate her quinceañera as planned this summer — and her Cinderella-like gown, ornate crown and shimmering jewelry helped ...

Preserved liver function and absence of metabolic dysfunction-associated steatotic liver disease or varices were associated with longer survival.

Discover a study on hepatocellular carcinoma showing how low-molecular-weight fucoidan enhances tumour control and preserves liver function with TACE.

Surrounded by loved ones in August, her quinceañera was more than a birthday celebration — it was a milestone of resilience, courage and determination When it came time for her quinceañera, a teen ...

Mysuru: A new study conducted by scientists at JSS Medical College, JSS Academy of Higher Education and Research (JSSAHER), explored the therapeutic p.

Discover a study showing how HCV eradication with antivirals during immunotherapy improves survival, liver function, and treatment outcomes in advanced hepatocellular carcinoma.